Lazard Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24K | Sell |
|
|||||
|
2025
Q1 | $1.36M | Sell |
|
|||||
|
2024
Q4 | $2.27M | Sell |
|
|||||
|
2024
Q3 | $4.28M | Sell |
|
|||||
|
2024
Q2 | $8.77M | Buy |
|
|||||
|
2024
Q1 | $976K | Sell |
|
|||||
|
2023
Q4 | $1.1M | Hold |
|
|||||
|
2023
Q3 | $1.08M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $5K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $375K | Sell |
|
|||||
|
2017
Q2 | $775K | Sell |
|
|||||
|
2017
Q1 | $2.18M | Sell |
|
|||||
|
2016
Q4 | $370M | Sell |
|
|||||
|
2016
Q3 | $798M | Buy |
|
|||||
|
2016
Q2 | $783M | Buy |
|
|||||
|
2016
Q1 | $774M | Buy |
|
|||||
|
2015
Q4 | $904M | Buy |
|
|||||
|
2015
Q3 | $725M | Sell |
|
|||||
|
2015
Q2 | $1.04B | Sell |
|
|||||
|
2015
Q1 | $1.25B | Buy |
|
|||||
|
2014
Q4 | $1.1B | Buy |
|
|||||
|
2014
Q3 | $958M | Buy |
|
|||||
|
2014
Q2 | $801M | Buy |
|
|||||
|
2014
Q1 | $264M | Sell |
|
|||||
|
2013
Q4 | $215M | Buy |
|
|||||
|
2013
Q3 | $135M | Sell |
|
|||||
|
2013
Q2 | $149M | Buy |
|